/ biotech stocks
/ Market Analysis
Why did ABVX Surge Over 400% in Premarket Trading?
Abivax shares surged over 400% in premarket trading after announcing positive Phase 3 results for its ulcerative colitis drug obefazimod.
July 23, 2025
Why Did Lyra Therapeutics’ Stock Rocket Past 440% in Premarket Today
Lyra Therapeutics stock surged in premarket trading after announcing positive Phase 3 trial results for a key treatment.
June 02, 2025
3 Biotech Stocks that Can Gain Exponentially By Leveraging AI
Although fraught with risk, these biotech exposures bring enormous upside potential.
July 02, 2024
These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains
These biotech stocks, lacking in profitability but seeding huge potential, should be on your watchlist.
June 14, 2024
Amid Biotech Pitfalls, this Stock Has Outperformed NVDA in the Last 3 Months
In the last three months, this biotech stock outperformed Nvidia (NVDA) by over 3x.
May 13, 2024More from The Tokenist / biotech stocks
Three Stocks to Diversify Beyond the Magnificent Seven in 2024
January 03, 2024
Premarket Moves: Nike Dips 11%, Karuna Therapeutics Soars 48%
December 22, 2023
Moderna Shares Jump 12% After Cancer Vaccine Shows Positive Results
December 14, 2023
These Three Biotech Stocks Are Trading at a Discount
November 23, 2023
2 Biotech Penny Stocks with a Strong Buy Consensus
January 23, 2021
3 Top Biotech Stocks to Hold Onto in September 2020
September 16, 2020
Back to 
